心肌梗死治疗应用低分子肝素钠的效果分析

Therapeutic Efficacy of Low Molecular Heparin Sodium for Myocardial Infarction

目的探讨心肌梗死治疗应用低分子肝素钠的效果。方法该院于2012年12月—2014年12月对102例心肌梗死患者进行回顾性分析,随机分为实验组和对照组各51例,对照组采用常规治疗方法进行治疗,实验组在对照组的基础上加入低分子肝素钠进行治疗,观察两组患者的治疗效果。结果实验组的总有效率(98.0%)明显高于对照组(78.4%),差异具有统计学意义(P<0.05)。结论对心肌梗死患者进行低分子肝素钠治疗可以更好的改善患者的症状,提高患者的生活质量,具有重要临床意义。

Objective To study the therapeutic efficacy of low molecular heparin sodium for myocardial infarction. Methods A retrospective analysis was performed on 102 patients with myocardial infarction in this hospital from December 2012 and December 2014. They were assigned to the control group in which the conventional therapy were performed and the experimental group in which the low molecular heparin sodium was used on the basis of conventional treatment with 51 in each one. The therapeutic efficacy of the two groups was compared. Results The total effective rate(98.0%) of the experimental group was significantly higher than that of the control group(78.4%) with statistical significance(P<0.05). Conclusion For patients with myocardial infarction, low molecular heparin sodium therapy can improve their symptom and quality of life, so this method has important clinical significance.